Key Takeaways, With Data for Alabama FDA approvals vary by drug: There are currently three GLP-1s on the market that the FDA has specifically approved to treat obesity
The Fund may be susceptible to an increased risk of loss, including losses due to adverse events that affect the Funds investments more than the market as a whole, to the extent that the Funds investments are concentrated in the securities and/or other assets of a particular issuer or issuers, country, group of countries, region, market, industry, group of industries, sector, market segment or asset class
Seek urgent medical attention if you develop high fever, severe back pain, persistent vomiting, or confusion, as these may indicate a serious infection requiring immediate assessment
No misleading claims
(Calculate your BMI here.) What is the physicians involvement in this program